155 related articles for article (PubMed ID: 34877724)
21. Leveraging Senescent Cancer Cell Membrane to Potentiate Cancer Immunotherapy Through Biomimetic Nanovaccine.
Yang C; Chen Y; Liu J; Zhang W; He Y; Chen F; Xie X; Tang J; Guan S; Shao D; Wang Z; Wang L
Adv Sci (Weinh); 2024 Jun; ():e2400630. PubMed ID: 38867377
[TBL] [Abstract][Full Text] [Related]
22. Reeducating Tumor-Associated Macrophages Using CpG@Au Nanocomposites to Modulate Immunosuppressive Microenvironment for Improved Radio-Immunotherapy.
Cao Y; Ding S; Zeng L; Miao J; Wang K; Chen G; Li C; Zhou J; Bian XW; Tian G
ACS Appl Mater Interfaces; 2021 Nov; 13(45):53504-53518. PubMed ID: 34704726
[TBL] [Abstract][Full Text] [Related]
23. Multifunctional silica nanocomposites prime tumoricidal immunity for efficient cancer immunotherapy.
Yang L; Li F; Cao Y; Liu Q; Jing G; Niu J; Sun F; Qian Y; Wang S; Li A
J Nanobiotechnology; 2021 Oct; 19(1):328. PubMed ID: 34663354
[TBL] [Abstract][Full Text] [Related]
24. Enhanced Antitumor Immune Responses via a Self-Assembled Carrier-Free Nanovaccine.
Liu D; Deng B; Liu Z; Ma B; Leng X; Kong D; Ji T; Liu L
Nano Lett; 2021 May; 21(9):3965-3973. PubMed ID: 33886338
[TBL] [Abstract][Full Text] [Related]
25. A Versatile Nanovaccine Enhancement Strategy Based on Suction-Inspired Physical Therapy.
Wu J; Feng Y; Guo X; Meng M; Li H; Fang H; Li Z; Lin L; Guo Z; Chen J; Tian H; Chen X
ACS Nano; 2024 Feb; 18(6):4957-4971. PubMed ID: 38288709
[TBL] [Abstract][Full Text] [Related]
26. Near-infrared light and magnetic field dual-responsive porous silicon-based nanocarriers to overcome multidrug resistance in breast cancer cells with enhanced efficiency.
Li J; Zhang W; Gao Y; Tong H; Chen Z; Shi J; Santos HA; Xia B
J Mater Chem B; 2020 Jan; 8(3):546-557. PubMed ID: 31854435
[TBL] [Abstract][Full Text] [Related]
27. An Immunomodulatory Zinc-Alum/Ovalbumin Nanovaccine Boosts Cancer Metalloimmunotherapy Through Erythrocyte-Assisted Cascade Immune Activation.
Zhao J; Zhang L; Li P; Liu S; Yu S; Chen Z; Zhu M; Xie S; Ling D; Li F
Adv Sci (Weinh); 2024 Feb; 11(6):e2307389. PubMed ID: 38064201
[TBL] [Abstract][Full Text] [Related]
28. Tumor Cell Nanovaccines Based on Genetically Engineered Antibody-Anchored Membrane.
Li Y; Zhang H; Wang R; Wang Y; Li R; Zhu M; Zhang X; Zhao Z; Wan Y; Zhuang J; Zhang H; Huang X
Adv Mater; 2023 Mar; 35(13):e2208923. PubMed ID: 36715052
[TBL] [Abstract][Full Text] [Related]
29. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence.
Li M; Guo R; Wei J; Deng M; Li J; Tao Y; Li M; He Q
Acta Biomater; 2021 Dec; 136():546-557. PubMed ID: 34536603
[TBL] [Abstract][Full Text] [Related]
30. Tumor microenvironment responsive FePt/MoS
Zhang D; Cui P; Dai Z; Yang B; Yao X; Liu Q; Hu Z; Zheng X
Nanoscale; 2019 Nov; 11(42):19912-19922. PubMed ID: 31599915
[TBL] [Abstract][Full Text] [Related]
31. Biomimetic manganese-eumelanin nanocomposites for combined hyperthermia-immunotherapy against prostate cancer.
Liu Y; Shang W; Liu H; Hui H; Wu J; Zhang W; Gao P; Guo K; Guo Y; Tian J
J Nanobiotechnology; 2022 Jan; 20(1):48. PubMed ID: 35073918
[TBL] [Abstract][Full Text] [Related]
32. Multifunctional pDNA-Conjugated Polycationic Au Nanorod-Coated Fe3 O4 Hierarchical Nanocomposites for Trimodal Imaging and Combined Photothermal/Gene Therapy.
Hu Y; Zhou Y; Zhao N; Liu F; Xu FJ
Small; 2016 May; 12(18):2459-68. PubMed ID: 26996155
[TBL] [Abstract][Full Text] [Related]
33. Nanoparticles with rough surface improve the therapeutic effect of photothermal immunotherapy against melanoma.
Xue J; Zhu Y; Bai S; He C; Du G; Zhang Y; Zhong Y; Chen W; Wang H; Sun X
Acta Pharm Sin B; 2022 Jun; 12(6):2934-2949. PubMed ID: 35755278
[TBL] [Abstract][Full Text] [Related]
34. An Intelligent Biomimetic Nanoplatform for Holistic Treatment of Metastatic Triple-Negative Breast Cancer
Cheng Y; Chen Q; Guo Z; Li M; Yang X; Wan G; Chen H; Zhang Q; Wang Y
ACS Nano; 2020 Nov; 14(11):15161-15181. PubMed ID: 33143424
[TBL] [Abstract][Full Text] [Related]
35. Enhanced photothermal therapy of biomimetic polypyrrole nanoparticles through improving blood flow perfusion.
Wang X; Li H; Liu X; Tian Y; Guo H; Jiang T; Luo Z; Jin K; Kuai X; Liu Y; Pang Z; Yang W; Shen S
Biomaterials; 2017 Oct; 143():130-141. PubMed ID: 28800434
[TBL] [Abstract][Full Text] [Related]
36. Core-shell FePt-cube@covalent organic polymer nanocomposites: a multifunctional nanocatalytic agent for primary and metastatic tumor treatment.
Meng Y; Zhang D; Sun Y; Dai Z; Zhang T; Yu D; Zhang G; Zheng X
J Mater Chem B; 2020 Dec; 8(48):11021-11032. PubMed ID: 33191409
[TBL] [Abstract][Full Text] [Related]
37. Self-Adjuvanted Molecular Activator (SeaMac) Nanovaccines Promote Cancer Immunotherapy.
Luo Z; He T; Liu P; Yi Z; Zhu S; Liang X; Kang E; Gong C; Liu X
Adv Healthc Mater; 2021 Apr; 10(7):e2002080. PubMed ID: 33336537
[TBL] [Abstract][Full Text] [Related]
38. Programming cell pyroptosis with biomimetic nanoparticles for solid tumor immunotherapy.
Zhao P; Wang M; Chen M; Chen Z; Peng X; Zhou F; Song J; Qu J
Biomaterials; 2020 Sep; 254():120142. PubMed ID: 32485591
[TBL] [Abstract][Full Text] [Related]
39. Self-actuated biomimetic nanocomposites for photothermal therapy and PD-L1 immunosuppression.
Li W; Li F; Li T; Zhang W; Li B; Liu K; Lun X; Guo Y
Front Chem; 2023; 11():1167586. PubMed ID: 37007061
[TBL] [Abstract][Full Text] [Related]
40. A Homotypic Membrane-Camouflaged Biomimetic Nanoplatform with Gold Nanocrystals for Synergistic Photothermal/Starvation/Immunotherapy.
Li Z; Rong L
ACS Appl Mater Interfaces; 2021 May; 13(20):23469-23480. PubMed ID: 33999610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
